Clinical Trial Update: Clinical and Pharmacogenetic Study of Attention Deficit With Hyperactivity Disorder (ADHD) [Phase 4]

View source ↗

Summary

Phase 4 clinical and pharmacogenetic study of Attention Deficit Hyperactivity Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Snippet

Sponsor: McGill University | Conditions: Attention Deficit Hyperactivity Disorder | Phase 4 | Status: COMPLETED